Robust Detection Of Minimal Residual Disease In Unselected Patients With B-Cell Precursor Acute Lymphoblastic Leukemia By High-Throughput Sequencing Of IGH

被引：0
|
作者：
Wu, David
Emerson, Ryan
Sherwood, Anna
Loh, Mignon L.
Angiolillo, Anne
Kirsch, Ilan
Carlson, Christopher S.
Williamson, David
Wood, Brent L.
Robins, Harlan
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.2550.2550
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2550
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping:: Method and significance
    Dworzak, MN
    Fritsch, G
    Panzer-Grümayer, ER
    Mann, G
    Gadner, H
    LEUKEMIA & LYMPHOMA, 2000, 38 (3-4) : 295 - +
  • [42] Effects of rituximab on the immunophenotype of benign B-cell precursors: Implications for flow cytometric minimal residual disease detection in precursor B-acute lymphoblastic leukemia
    Siami, K
    Awagu, S
    Cooper, DG
    Thomas, DA
    Huh, Y
    Jones, D
    Chen, W
    Jorgensen, JL
    LABORATORY INVESTIGATION, 2006, 86 : 246A - 247A
  • [43] Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia
    Kruse, Aaron
    Abdel-Azim, Nour
    Kim, Hye Na
    Ruan, Yongsheng
    Phan, Valerie
    Ogana, Heather
    Wang, William
    Lee, Rachel
    Gang, Eun Ji
    Khazal, Sajad
    Kim, Yong-Mi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (03)
  • [44] High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia
    Oikonomou, Athanasios
    Valsecchi, Luigia
    Quadri, Manuel
    Watrin, Titus
    Scharov, Katerina
    Procopio, Simona
    Tu, Jia-Wey
    Vogt, Melina
    Savino, Angela Maria
    Silvestri, Daniela
    Valsecchi, Maria Grazia
    Biondi, Andrea
    Borkhardt, Arndt
    Bhatia, Sanil
    Cazzaniga, Giovanni
    Fazio, Grazia
    Bardini, Michela
    Palmi, Chiara
    BIOCHEMICAL PHARMACOLOGY, 2023, 217
  • [45] Minimal Residual Disease Detection By Next Generation Sequencing in Adult B-Cell Acute Lymphoblastic Leukemia (ALL) Patients Treated on SWOG Trial S0333
    Torra, Olga Sala
    Othus, Megan
    Williamson, David W.
    Wood, Brent L.
    Kirsch, Ilan
    Robins, Harlan
    O'Donnell, Margaret
    Forman, Stephen J.
    Appelbaum, Frederick R.
    Radich, Jerald P.
    BLOOD, 2014, 124 (21)
  • [46] Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia
    Faham, Malek
    Zheng, Jianbiao
    Moorhead, Martin
    Carlton, Victoria E. H.
    Stow, Patricia
    Coustan-Smith, Elaine
    Pui, Ching-Hon
    Campana, Dario
    BLOOD, 2012, 120 (26) : 5173 - 5180
  • [47] Comparative analysis of a novel next-generation sequencing-based IGH clonality assay for measurable residual disease detection in pediatric B-cell acute lymphoblastic leukemia patients
    Park, Min-Seung
    Ju, Hee Young
    Lee, Ji Won
    Yoo, Keon Hee
    Kim, Hee-Jin
    Cho, Duck
    Kim, Hyun-Young
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2025, 42 (02) : 115 - 125
  • [48] Detailed clonality analysis of relapsing precursor B acute lymphoblastic leukemia: implications for minimal residual disease detection
    Li, AH
    Rosenquist, R
    Forestier, E
    Lindh, J
    Roos, G
    LEUKEMIA RESEARCH, 2001, 25 (12) : 1033 - 1045
  • [49] The significance of peripheral blood minimal residual disease to predict early disease response in patients with B-cell acute lymphoblastic leukemia
    Setiadi, A.
    Owen, D.
    Tsang, A.
    Milner, R.
    Vercauteren, S.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 (05) : 527 - 534
  • [50] Healthcare Resource Utilization in Adult Patients with B-Cell Precursor Acute Lymphoblastic Leukemia in First Hematologic Complete Remission with and without Minimal Residual Disease
    Rose, Darya
    Shah, Shweta
    Despiegel, Nicholas
    Tibrewala, Shruti
    Chawla, Anita
    Cong, Ze
    BLOOD, 2018, 132
12345